392 material Form 8-K filings that 341 companies we cover made with the SEC in July 2024, each read and summarized by AI: what happened, the key figures, whether it reads positive or negative for shareholders, and how big a deal it is (impact 1-5). All of them were written later, when past filings were added: a selection, not every 8-K of the month (see the note below).
ADMA Biologics promoted Brad Tade, its former vice president of financial operations, to chief financial officer and treasurer effective July 24, 2024. The company entered into an employment agreement with Mr. Tade, which sets a $435,000 base salary, a target bonus of 45% of salary, and equity grants of options and restricted stock units.
Brad Tade, age 51, joined ADMA in June 2023 as vice president, financial operations, and is now CFO and treasurer effective July 24, 2024
Base salary of $435,000 with a target annual cash bonus of 45% of base salary
Equity grant of an option to purchase 115,100 shares and 72,400 restricted stock units, vesting over four years
Casey's General Stores agreed on July 25, 2024 to acquire Fikes Wholesale, owner of CEFCO Convenience Stores, in an all-cash deal. The deal would add 198 retail stores and a dealer network, and the company says it is accretive to EBITDA in the current fiscal year, which is a company claim not yet tested by results. The deal is subject to regulatory review and is expected to close in the fourth quarter of 2024.
Aggregate cash purchase price of $1.145 billion, including tax benefits valued at about $165 million, for a net after-tax price of $980 million
Adds 198 stores and a dealer network, taking the footprint to nearly 2,900 stores; 148 stores are in Texas and 50 are in Alabama, Florida and Mississippi
Company plans to fund the deal with balance sheet cash and bank financing, and expects about $45 million in annual run-rate synergies
Expected to close in the fourth quarter of calendar 2024, subject to closing conditions including the Hart-Scott-Rodino waiting period
Colgate-Palmolive reported second quarter 2024 net sales of $5,058 million, up 4.9%, and GAAP diluted EPS of $0.89, up 48% from $0.60. The company raised its full-year 2024 organic sales growth guidance to 6% to 8% and its Base Business EPS growth guidance to 8% to 11%.
Organic sales grew 9.0% in the quarter; Base Business EPS rose 18% to $0.91
GAAP gross profit margin rose 280 basis points to 60.6%
Full-year 2024 organic sales growth guidance raised to 6% to 8% from 5% to 7%
Net sales growth guidance of 2% to 5% unchanged, including a mid-single-digit negative foreign exchange impact
Gentex reported second-quarter 2024 net sales of $572.9 million, down from $583.5 million a year earlier, and net income of $86.0 million, compared with $109.2 million. The company lowered its 2024 revenue and gross margin guidance, citing weaker light vehicle production and a sales shortfall in June, which reduces its outlook for shareholders.
Q2 2024 diluted EPS was $0.37, versus $0.47 in Q2 2023; gross margin was 32.9%, versus 33.1%.
Other loss of $13.5 million included $18.3 million in non-cash losses on tech investment holdings.
2024 revenue guidance cut to $2.40-$2.50 billion from $2.45-$2.55 billion; gross margin guidance cut to 34%-34.5% from 34%-35%.
2025 revenue estimate set at approximately $2.6-$2.7 billion.
Sensient reported second-quarter 2024 revenue of $403.5 million, up 7.8%, but operating income fell 3.7% to $49.7 million and diluted EPS fell 9.9% to 73 cents. The company raised its local currency revenue and adjusted EBITDA growth outlook, but narrowed its GAAP diluted EPS guidance lower by 3 cents at both ends to $2.77 to $2.87.
Revenue rose 7.8% to $403.5 million from $374.3 million a year earlier; operating income fell 3.7% to $49.7 million.
Diluted EPS was 73 cents versus 81 cents a year earlier, including $1.8 million of Portfolio Optimization Plan costs in the quarter.
Local currency revenue and adjusted EBITDA growth outlook raised to mid-to-high single digits from mid-single digits.
GAAP diluted EPS guidance lowered to between $2.77 and $2.87 from between $2.80 and $2.90; the company also posted an updated investor presentation on July 26, 2024.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.
Briefs marked “Written later” were written in November 2026 for filings that were by then more than three weeks old, so months before mid-October 2026 hold a selection: every material 8-K of the past year for the 100 largest companies we cover and the last 15 important 8-Ks of every other one. Briefs the number check holds back are not shown or counted. Also: the last 45 days, briefs by company, A–Z and the live SEC filings wire.